Department of Medical Laboratory Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
School of Medical Laboratory Science, College of Health Science, Wolaita Sodo University, Wolaita Sodo, Ethiopia.
Cancer Med. 2024 Jun;13(11):e7376. doi: 10.1002/cam4.7376.
Acute myeloid leukemia (AML) is aggressive type of hematological malignancy. Its poses challenges in early diagnosis, necessitating the identification of an effective biomarker. This study aims to assess the diagnostic accuracy of long noncoding RNAs (lncRNA) in the diagnosis of AML through a meta-analysis. The study is registered on the PROSPERO website with the number 493518.
A literature search was conducted in the PubMed, Embase, Hinari, and the Scopus databases to identify relevant studies. We pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the summary receiver operating characteristics (ROC) using Stata 14.1 software. Heterogeneity between studies was determined through the I statistic and Cochran-Q test. A random effect model was chosen due to significant heterogeneity among included studies. Meta-regression and subgroup analysis were performed to assess the potential source of heterogeneity. Furthermore, potential publication bias was estimated using Deek's funnel plot asymmetry test.
A total of 14 articles covering 19 studies were included in this meta-analysis comprising 1588 AML patients and 529 healthy participants. The overall pooled sensitivity, specificity, PLR, NLR, DOR, and the area under the summary ROC curve were 0.85 (95% CI = 0.78-0.91), 0.82 (95% CI = 0.72-0.89), 4.7 (95% CI = 2.9-7.4), 0.18 (95% CI = 0.12-0.28), 26 (95% CI = 12-53), and 0.90 (95% CI = 0.87-0.93), respectively. Moreover, lncRNAs from non-bone marrow mononuclear cells (BMMC) had superior diagnostic value with pooled sensitivity, specificity, and AUC were 0.93, 0.82, and 0.95, respectively.
This meta-analysis demonstrated that circulating lncRNAs can serve as potential diagnostic markers for AML. High accuracy of diagnosis was observed in non-BMMC lncRNAs, given cutoff value, and the GADPH internal reference gene used. However, further studies with large sample size are required to confirm our results.
急性髓系白血病(AML)是一种侵袭性血液系统恶性肿瘤。AML 的早期诊断存在挑战,因此需要寻找有效的生物标志物。本研究旨在通过荟萃分析评估长链非编码 RNA(lncRNA)在 AML 诊断中的准确性。本研究已在 PROSPERO 网站上注册,注册号为 493518。
通过在 PubMed、Embase、Hinari 和 Scopus 数据库中进行文献检索,以确定相关研究。我们使用 Stata 14.1 软件汇总了敏感度、特异度、阳性似然比(PLR)、阴性似然比(NLR)、诊断比值比(DOR)和汇总受试者工作特征(ROC)曲线下面积。通过 I ²统计量和 Cochran-Q 检验来确定研究间的异质性。由于纳入研究之间存在显著异质性,因此选择了随机效应模型。进行 Meta 回归和亚组分析以评估潜在的异质性来源。此外,通过 Deek 的漏斗图不对称检验估计潜在的发表偏倚。
该荟萃分析共纳入了 14 篇文章,涉及 19 项研究,包括 1588 例 AML 患者和 529 例健康参与者。总的汇总敏感度、特异度、PLR、NLR、DOR 和汇总 ROC 曲线下面积分别为 0.85(95%CI=0.78-0.91)、0.82(95%CI=0.72-0.89)、4.7(95%CI=2.9-7.4)、0.18(95%CI=0.12-0.28)、26(95%CI=12-53)和 0.90(95%CI=0.87-0.93)。此外,来自非骨髓单核细胞(BMMC)的 lncRNA 具有更好的诊断价值,其汇总敏感度、特异度和 AUC 分别为 0.93、0.82 和 0.95。
本荟萃分析表明,循环 lncRNA 可作为 AML 的潜在诊断标志物。在非 BMMC lncRNA 中,当使用截断值和 GADPH 内参基因时,诊断准确性较高。但是,需要更大样本量的研究来验证我们的结果。